Xiangcai Co

Xiangcai Co EBIT Growth

The Year-over-Year EBIT Growth of Xiangcai Co (600095.SS) as of Oct 22, 2026 is -39.76 %. In the previous year, Year-over-Year EBIT Growth was 109.96 % — a change of -136.15% (lower).

EBIT Growth

-39.76 %

YoY

-136.15%

Last updated:

Year-over-Year EBIT Growth of Xiangcai Co is 2025 -39.76 % . Year-over-Year EBIT Growth of Xiangcai Co was 2024 109.96 % . It decreases by -136.15% lower compared to the previous year.

The Xiangcai Co EBIT Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Growth
Date
EBIT Growth
Jan 1, 2018
-17.55 CNY
Jan 1, 2019
1,543.79 CNY
Jan 1, 2020
-10.96 CNY
Jan 1, 2021
79.06 CNY
Jan 1, 2022
-138.01 CNY
Jan 1, 2023
158.11 CNY
Jan 1, 2024
109.96 CNY
Jan 1, 2025
-39.76 CNY
The Xiangcai Co EBIT Growth history
YEAREBIT GrowthYoY
-39.76 %-136.15%
109.96 %-30.45%
158.11 %-214.56%
-138.01 %-274.57%
79.06 %-821.13%
-10.96 %-100.71%
1,543.79 %-8,898.89%
-17.55 %-720.69%
2.83 %-99.82%
1,611.32 %-1,993.99%
-85.08 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Xiangcai Co Stock analysis

What does Xiangcai Co do? Xiangcai Co., Ltd. generates revenue through multiple business segments including non-GMO soybean products processing, pharmaceuticals, waterproof membrane manufacturing, and industrial plants. The company produces soybean protein isolate, soybean tissue protein, and soybean nutritious food under its soybean deep processing division. Its pharmaceutical segment focuses on thymopeptide enteric-coated tablets and other immune system treatment drugs. The waterproof membrane business manufactures and sells polyethylene polypropylene fiber coils, load-bearing coils, and joint profiles. Real estate development and property management contribute to the company's revenue through residential and industrial real estate projects. The primary buyers for soybean deep processing products include food manufacturers and health supplement companies seeking non-GMO ingredients. Pharmaceutical customers consist of hospitals, pharmacies, and healthcare providers purchasing thymopeptide enteric-coated tablets for immune system treatments. Waterproof membrane products are sold to construction companies and building contractors for infrastructure and residential projects. Real estate clients are residential buyers and industrial tenants requiring property development and management services. Xiangcai Co., Ltd. serves distinct market segments: food and beverage manufacturers for soybean products, healthcare institutions for pharmaceuticals, construction firms for waterproofing solutions, and residential/industrial property occupants for real estate services. The company's product portfolio spans from raw material processing to end-user applications across these sectors, creating diversified revenue streams. Xiangcai Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Xiangcai Co stock

Year-over-Year EBIT Growth of Xiangcai Co is -39.76 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year EBIT Growth Xiangcai Co since 2006 – with annual values, charts, and detailed analysis.

EBIT growth measures the percentage change in operating earnings. It shows whether a company's core operations are becoming more profitable.

To evaluate Year-over-Year EBIT Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBIT Growth.

Year-over-Year EBIT Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBIT Growth's Xiangcai Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Xiangcai Co

All Key Metrics — Xiangcai Co